# Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/nivolumab-plus-ipilimumab-in-lung-cancer-with-a-high-tumor-mutational-burden/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Matthew D. Hellmann,Tudor–Eliade Ciuleanu,Adam Płużański,Jong Seok Lee,Gregory A. Otterson,Clarisse Audigier-Valette,Elisa Minenza,Helena Linardou,Sjaak A. Burgers,Pamela Salman,Hossein Borghaei,Suresh S. Ramalingam,Julie R. Brahmer,Martin Reck,Kenneth J. O’Byrne,William J. Geese,George Green,Chang Han,Joseph D. Szustakowski,Prabhu Bhagavatheeswaran,Diane Healey,Yali Fu,Faith E. Nathan,Luis Paz‐Ares |
| Citations | 3,158 |
| DOI | 10.1056/nejmoa1801946 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJMoa1801946?articleTools=true |
| OpenAlex ID | https://openalex.org/W2797675588 |
| PMID | 29658845 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Matthew D. Hellmann](https://scholariq.org/researchers/matthew-d-hellmann/)
- [Julie R. Brahmer](https://scholariq.org/researchers/julie-r-brahmer/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Radiomics and Machine Learning in Medical Imaging](https://scholariq.org/topics/radiomics-and-machine-learning-in-medical-imaging/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.